Literature DB >> 33744297

Real-World Application of a Noninvasive Two-Gene Expression Test for Melanoma Diagnosis.

Michael A Marchetti1, Japbani K Nanda2, Silvia E Mancebo3, Stephen W Dusza2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33744297      PMCID： PMC8384641          DOI： 10.1016/j.jid.2021.03.005

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   7.590


× No keyword cloud information.
  13 in total

1.  Impact on clinical practice of a non-invasive gene expression melanoma rule-out test: 12-month follow-up of negative test results and utility data from a large US registry study.

Authors:  Laura K Ferris; Darrell S Rigel; Daniel M Siegel; Maral K Skelsey; Gary L Peck; Catherine Hren; Christopher Gorman; Tana Frumento; Burkhard Jansen; Zuxu Yao; Jim Rock; Stevan R Knezevich; Clay J Cockerell
Journal:  Dermatol Online J       Date:  2019-05-15

2.  Further Consideration of the Pigmented Lesion Assay.

Authors:  Meghan Beatson; Martin A Weinstock
Journal:  JAMA Dermatol       Date:  2019-03-01       Impact factor: 10.282

3.  Noninvasive Gene Expression Testing in Amelanotic Melanoma.

Authors:  Maria V Childs
Journal:  JAMA Dermatol       Date:  2018-02-01       Impact factor: 10.282

4.  Real-World Utility of a Non-Invasive Gene Expression Test to Rule Out Primary Cutaneous Melanoma: A Large US Registry Study.

Authors:  Brook Brouha; Laura K Ferris; Maral K Skelsey; Gary Peck; Ronald Moy; Zuxu Yao; Burkhard Jansen
Journal:  J Drugs Dermatol       Date:  2020-03-01       Impact factor: 2.114

5.  Real-world performance and utility of a noninvasive gene expression assay to evaluate melanoma risk in pigmented lesions.

Authors:  Laura K Ferris; Pedram Gerami; Maral K Skelsey; Gary Peck; Catherine Hren; Christopher Gorman; Tana Frumento; Daniel M Siegel
Journal:  Melanoma Res       Date:  2018-10       Impact factor: 3.599

6.  PRAME Expression in Melanocytic Tumors.

Authors:  Cecilia Lezcano; Achim A Jungbluth; Kishwer S Nehal; Travis J Hollmann; Klaus J Busam
Journal:  Am J Surg Pathol       Date:  2018-11       Impact factor: 6.394

7.  Economic Analysis of a Noninvasive Molecular Pathologic Assay for Pigmented Skin Lesions.

Authors:  John Hornberger; Daniel M Siegel
Journal:  JAMA Dermatol       Date:  2018-09-01       Impact factor: 10.282

8.  STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration.

Authors:  Jérémie F Cohen; Daniël A Korevaar; Douglas G Altman; David E Bruns; Constantine A Gatsonis; Lotty Hooft; Les Irwig; Deborah Levine; Johannes B Reitsma; Henrica C W de Vet; Patrick M M Bossuyt
Journal:  BMJ Open       Date:  2016-11-14       Impact factor: 2.692

9.  Development and validation of a noninvasive 2-gene molecular assay for cutaneous melanoma.

Authors:  Pedram Gerami; Zuxu Yao; David Polsky; Burkhard Jansen; Klaus Busam; Jonhan Ho; Mary Martini; Laura K Ferris
Journal:  J Am Acad Dermatol       Date:  2016-10-01       Impact factor: 11.527

10.  Use of the Pigmented Lesion Assay to rapidly screen a patient with numerous clinically atypical pigmented lesions.

Authors:  Aatman Shah; John Hyngstrom; Scott R Florell; Douglas Grossman
Journal:  JAAD Case Rep       Date:  2019-11-20
View more
  2 in total

1.  An Epidemiologic Analysis of Melanoma Overdiagnosis in the United States, 1975-2017.

Authors:  Nicholas R Kurtansky; Stephen W Dusza; Allan C Halpern; Rebecca I Hartman; Alan C Geller; Ashfaq A Marghoob; Veronica M Rotemberg; Michael A Marchetti
Journal:  J Invest Dermatol       Date:  2021-12-11       Impact factor: 7.590

2.  Detection of cutaneous malignant melanoma using RNA sampled by tape strips: A study protocol.

Authors:  Ida M Heerfordt; Jeppe D Andersen; Peter A Philipsen; Linnea Langhans; Torben Tvedebrink; Grethe Schmidt; Thomas Poulsen; Catharina M Lerche; Niels Morling; Hans Christian Wulf
Journal:  PLoS One       Date:  2022-09-21       Impact factor: 3.752
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.